AJR F and L Medical Products: Radiation Protection & More
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by deSouza, N. M.
Right arrow Articles by Soutter, W. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by deSouza, N. M.
Right arrow Articles by Soutter, W. P.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?
AJR 2005; 184:999-1003
© American Roentgen Ray Society

Original Report

Borderline Tumors of the Ovary: CT and MRI Features and Tumor Markers in Differentiation from Stage I Disease

Nandita M. deSouza1,2, Richard O'Neill1, G. Angus McIndoe3, Roberto Dina4 and W. Patrick Soutter3

1 Department of Imaging, Hammersmith Hospital, DuCane Rd., London W12 0HS, England.
2 Present address: Section of Magnetic Resonance Imaging, Institute of Cancer Research, Royal Marsden Hospital, Downs Rd., Sutton, Surrey SM2 5PT, England.
3 Department of Gynaecological Oncology, Hammersmith Hospital, London W12 0HS, England.
4 Department of Histopathology, Hammersmith Hospital, London W12 0HS, England.

OBJECTIVE. We sought to describe MDCT and MRI features and tumor marker levels that differentiate borderline ovarian tumors from stage I ovarian tumors.

CONCLUSION. Borderline ovarian tumors are complex masses with imaging features similar to stage I tumors. The thickness of septations and the size of solid components are significantly larger in stage I tumors, and these features may be helpful for predicting likelihood of invasive tumors. However, neither feature allows confident differentiation of borderline tumors from stage I disease.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Roentgen Ray Society.